Prevision Medicine tests a patient's own living cancer cells against 100+ drugs and combinations to help physicians make more informed treatment decisions.

Founders

• Yannik Severin · Chief Scientific Officer (CSO) & Co-Founder
  He originally joined Berend Snijder’s group as its first PhD student and helped build the Zurich lab from the ground up.
• Valentin Matillon · Chief Business Officer (CBO) & Co-Founder
  He has more than 25 years of experience in senior financial-management positions and more than a decade in the startup ecosystem focused on scaling biotech companies.
• Philip Zimmermann · Chief Executive Officer (CEO) & Co-Founder
  He has a deep history in precision medicine and bioinformatics and holds a PhD in Life Sciences from ETH Zurich.
• Berend Snijder · Scientific Co-Founder and Chairman of the Board
  He is a faculty member at the Botnar Institute of Immune Engineering, a group leader at the Swiss Institute of Bioinformatics and the Comprehensive Cancer Center Zurich, a former Assistant Professor at ETH Zurich, and a co-founder of Allcyte and Graph Therapeutics.

Customers

Inselspital Bern